Organization | Lenox Hill Hospital

Lenox Hill Hospital Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: New York NY United States (1857)

Organization Overview

First Clinical Trial

2002

NCT00161733

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Alexandra Black | Lenox Hill Hospital | Lenox Hill Hospital, New York, NY

Active Ingredients

Drugs in Phase 4 Trials (7)

acetylsalicylic acid (aspirin) (1 trial)

bupivacaine (Exparel) (1 trial)

nicardipine (cardene) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

paclitaxel (taxol) (1 trial)

prasugrel (effient) (1 trial)

verapamil (calan) (1 trial)

Drugs in Phase 3 Trials (1)

human fibrin (1 trial)

Drugs in Phase 2 Trials (3)

abaloparatide (tymlos) (1 trial)

bevacizumab (avastin) (1 trial)

carboplatin (paraplatin) (1 trial)

Drugs in Other Trials (2)

ga-68-dota-toc (Ga-68-dota-toc) (1 trial)

sodium bicarbonate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Astrocytoma (Phase 2)

Fractures, Bone (Phase 2)

Glioblastoma (Phase 2)

Hip Fractures (Phase 2)

Vasospasm, Intracranial (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 13